Jönsson, Bengt http://orcid.org/0000-0002-0051-7785
Hampson, Grace http://orcid.org/0000-0002-2019-1268
Michaels, Jonathan http://orcid.org/0000-0002-3422-7102
Towse, Adrian
von der Schulenburg, J.-Matthias Graf http://orcid.org/0000-0002-5322-9453
Wong, Olivier http://orcid.org/0000-0002-7344-7837
Funding for this research was provided by:
Kite Pharma, a Gilead company
Article History
Received: 4 March 2018
Accepted: 11 September 2018
First Online: 18 September 2018
Compliance with ethical standards
:
: All authors report receipt of consultancy fees from Kite Pharma in relation to this work. In addition, Grace Hampson is an employee of the Office of Health Economics, a registered charity, which receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry. Jonathan Michaels has have been in receipt of funding from the NIHR in the UK for ongoing research projects that are unrelated to this paper, and participated in a mock appraisal process for regenerative medicines carried out by the National Institute for Health and Care Excellence (NICE). Adrian Towse is an employee of the Office of Health Economics, a registered charity, which receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry. Olivier Wong is Chief Medical Office of Medi-Qualite Omega SARL and the company receives fees from various life science industries.